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ttp://dx.doi.org/10.1016/j.ajpath.2013.01.034Accumulation of b-amyloid (Ab) in the brain is a key event in Alzheimer disease pathogenesis. Apoli-
poprotein (Apo) E is a lipid carrier protein secreted by astrocytes, which shows inherent afﬁnity for Ab and
has been implicated in the receptor-mediated Ab uptake by neurons. To characterize ApoE involvement in
the intraneuronal Ab accumulation and to investigate whether blocking the ApoE/Ab interaction could
reduce intraneuronal Ab buildup, we used a noncontact neuronal-astrocytic co-culture system, where
synthetic Ab peptides were added into the media without or with cotreatment with Ab12-28P, which is
a nontoxic peptide antagonist of ApoE/Ab binding. Compared with neurons cultured alone, intraneuronal
Ab content was signiﬁcantly increased in neurons co-cultured with wild-type but not with ApoE knockout
(KO) astrocytes. Neurons co-cultured with astrocytes also showed impaired intraneuronal degradation of
Ab, increased level of intraneuronal Ab oligomers, and marked down-regulation of several synaptic
proteins. Ab12-28P treatment signiﬁcantly reduced intraneuronal Ab accumulation, including Ab olig-
omer level, and inhibited loss of synaptic proteins. Furthermore, we showed signiﬁcantly reduced
intraneuronal Ab accumulation in APPSW/PS1dE9/ApoE KO mice compared with APPSW/PS1dE9/ApoE tar-
geted replacement mice that expressed various human ApoE isoforms. Data from our co-culture and in vivo
experiments indicate an essential role of ApoE in the mechanism of intraneuronal Ab accumulation and
provide evidence that ApoE/Ab binding antagonists can effectively prevent this process. (Am J Pathol
2013, 182: 1750e1768; http://dx.doi.org/10.1016/j.ajpath.2013.01.034)Supported by grants from the NIH National Institute on Aging (R01
AG31221 and K02 AG34176 to M.J.S.; R37 AG13956 to D.M.H.) and by
a Hartford/AFAR Beeson Scholars Collaborative Award (M.J.S. and
D.M.H.).Long-term accumulation of a toxic and insoluble b-amyloid
(Ab) peptide in the brain of patients with Alzheimer disease
(AD) triggers a neurodegenerative cascade that involves
widespread synaptic degeneration, formation of neuroﬁ-
brillary tangles, and neuronal loss, which result in
progressive dementia.1,2 Buildup of Ab is a result of
a disequilibrium between the rate of its generation and the
rate of its brain clearance3 and is driven by inherently low
solubility and natural propensity of Ab to self-assemble into
oligomers and ﬁbrils.4 Ab ﬁbrils, which are deposited as
senile plaques and cerebral amyloid angiopathy (CAA),
together with neuroﬁbrillary tangles and synaptic degener-
ation, constitute neuropathologic hallmarks of AD. There isstigative Pathology.
.also evidence of intraneuronal Ab accumulation in addition
to the extracellular Ab plaques and CAA, which may also
contribute importantly to the Ab-induced neurodegenerative
cascade.5e7
A number of studies have associated intraneuronal Ab
buildup with hyperphosphorylation of tau protein,8 disturbed
protein trafﬁcking and sorting,9 reduced expression of
synaptic proteins,10 and mitochondrial dysfunction.11,12
Ab12-28P Reduces Intraneuronal AbApolipoprotein E (ApoE) is a 34-kDa lipid carrier protein
with inherent afﬁnity for Ab, which is involved in multiple
aspects of Ab metabolism, including formation of Ab pla-
ques and CAA and impairment of Ab brain clearance.13 The
pivotal role of ApoE in brain Ab accumulation was
conﬁrmed by showing a marked reduction in Ab plaque and
CAA deposits associated with the Apoe gene knockout
(KO) in AD transgenic (Tg) mice.14 In the brain, ApoE is
produced by astrocytes, which secrete ApoE-containing
lipoprotein particles into the interstitial ﬂuid from where
they are internalized by neurons through receptor-mediated
endocytosis. The propensity of ApoE to bind Ab and its
efﬁcient internalization by neurons implicates ApoE in
promoting neuronal Ab uptake.15 To characterize the role of
ApoE in intraneuronal Ab accumulation and to test the
hypothesis that a therapeutic agent blocking the ApoE/Ab
binding could ameliorate intraneuronal Ab buildup, we
developed a noncontact, co-culture model that combined
primary hippocampal neurons and astrocytes as a source of
native, lipidated ApoE particles (Figure 1). The ApoE/Ab
binding was blocked with Ab12-28P, which is a nontoxic,
synthetic peptide modiﬁed for increased blood-brain-barrier
(BBB) permeability and extended serum half-life.16 As we
have previously shown, Ab12-28P inhibits ApoE4/Ab
binding with KI Z 12.9 nmol/L, neutralizes the promoting
effect of ApoE on Ab ﬁbrillization in vitro, and reduces the
load of Ab plaques and CAA when systemically adminis-
tered to APPSW Tg mice.
22 In a complementary in vivo
study included here, we analyzed the effect of ApoE KO
and the effect of various human ApoE isoforms on the
intraneuronal Ab accumulation in newly developed APPSW/
PS1dE9/ApoE KO and APPSW/PS1dE9/ApoE-TR (targeted
replacement) mice. Our studies emphasize the pivotal role
of ApoE in intraneuronal Ab accumulation and show the
beneﬁts of pharmacologic targeting of the ApoE/Ab inter-
action on intraneuronal Ab levels and neurodegeneration.Figure 1 Noncontact, co-culture system of primary hippocampal neurons and
seeded on the Transwell insert are suspended above a monolayer of primary hipp
synthetic Ab peptides are directly added into the conditioned media. B: Microph
counterstained with DAPI. C: Microphotograph of sentinel primary hippocampal n
marker MAP2 and counterstained with DAPI. D: Western immunoblot analyses of
hippocampal neurons cultured alone (lane 1), primary hippocampal neurons co-cu
days in vitro; GFAP, glial ﬁbrillary acidic protein; MAP2, microtubule-associated p
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Materials and Reagents
All Ab peptides were custom synthesized in the WM Keck
Proteomic Facility of Yale University (New Haven, CT).
Unlabeled peptides were provided by the laboratory of Dr.
James I. Elliott (Yale University), and ﬂuorescein-taggedAb1-
40 was synthesized by the laboratory of Dr. Janet Crawford
(Yale University). PCR primers were custom synthesized by
Gene Link (Hawthorne, NY). Recombinant human APOE4
was bought from Leinco Technologies, Inc. (St. Louis, MO).
Cell culture plasticware, including Transwell inserts with 0.4-
mm pore size, were purchased from Corning Incorporated
(Corning, NY). Cell culture media and human aggregated Ab
enzyme-linked immunosortbent assay (ELISA) kit were
purchased from Invitrogen Life Technologies (Carlsbad, CA).
Complete Protease Inhibitor Cocktail was obtained from
Roche Applied Science (Indianapolis, IN). A kit for bicin-
choninic acid assay and the SuperSignal chemiluminescent
reagent for immunoblotting were obtained from Pierce
Biotechnology Inc. (Rockford, IL). Nitrocellulose membrane
and horseradish peroxidase-conjugated secondary antibodies
(Abs) for immunoblot analysis were sheep anti-mouse and
donkey anti-rabbit (GE Healthcare Bio-Sciences Corp., Pis-
cataway,NJ). Immobilon polyvinylidene diﬂuoridemembrane
and Microcon centrifugal ﬁlter devices were purchased from
Millipore Corporation (Billerica, MA). Autoradiography ﬁlms
X-Omat Blue XB-1 were bought from Eastman Kodak
Company (New Haven, CT). Mouse on mouse (MOM)
peroxidase kit, MOM blocking reagent, streptavidin/biotin
blocking kit, and biotinylated secondary Abs included goat
anti-mouse IgG and goat anti-rabbit IgG used for immuno-
cytochemistry and immunohistochemistry (Vector Laborato-
ries, Ltd., Burlingame, CA). All other reagents were purchased
from Sigma-Aldrich (St. Louis, MO). Primary Abs wereastrocytes. A: Diagram of neuronal-astrocytic co-culture system. Astrocytes
ocampal neurons grown on the bottom of the well, whereas monomers of
otograph of sentinel astrocytic cultures immunostained against GFAP and
euronal culture at seven DIV immunostained against neuronal cytoskeleton
murine ApoE and b-actin used as a loading control from lysates of primary
ltured with astrocytes (lane 2), and astrocytes cultured alone (lane 3). DIV,
rotein 2. Scale bars: 20 mM (B and C).
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Kuszczyk et alobtained from several different sources, and their listing,
together with working dilutions, is provided in Table 1.
HJ6.1 is a novel monoclonal antibody (mAb) against murine
ApoE. It was generated with ApoE lipoprotein particles
puriﬁed by afﬁnity chromatography from media of primary
astrocytic cultures established from C57BL/6 mice. Puriﬁed
astrocyte-secreted ApoE lipoprotein particles were injected
with complete Freund adjuvant to ApoE KO mice. For an
initial screening of Abs, supernatant ﬂuids from hybridoma
cells (approximately 2000 wells) were added to 96-well
plates coated with puriﬁed astrocyte-secreted ApoE lipo-
protein particles. With the use of anti-mouse IgG-horse-
radish peroxidase as a detection antibody, we initially
identiﬁed 36 clones and then subcloned them to ﬁnd those
that performed well in several biochemical and immuno-
histochemical assays.
Mice
All mouse care and experimental procedures were approved
by Institutional Animal Care and Use Committees of the New
York University School of Medicine and the Washington
University School of Medicine. Cultures of primary hippo-
campal neurons and astrocytes were established from pups of
C57BL/6 mice, whose breeding pairs were obtained from
Charles River Laboratories (Wilmington, MA). Additional
astrocytic cultures were established from ApoE KO mice
described previously.17 To develop the APPSW/PS1dE9/ApoETable 1 List of Antibodies Used in the Study
Antigen
Clone
(symbol) Type
Ab residues 1e16 6E10 Mouse monoclonal
Ab residues 17e24 4G8 Mouse monoclonal
Ab residues 1e16 HJ3.4 Mouse monoclonal
Ab40 C-terminus speciﬁc HJ2 Mouse monoclonal
Ab42 C-terminus speciﬁc HJ7.4 Mouse monoclonal
Ab oligomeric A11 Rabbit polyclonal
ApoE murine HJ6.1 Mouse Monoclonal
APP N-terminus 22C11 Mouse monoclonal
APP C-terminus A8717 Rabbit polyclonal
a-Tubulin DM1A Mouse monoclonal
b-Actin N-terminus AC-15 Mouse monoclonal
Cathepsin D H-75 Rabbit polyclonal
EEA1 G-4 Mouse monoclonal
HSP60 residues 288e366 HSP60 Mouse monoclonal
GFAP 3H2 Mouse monoclonal
GFAP N1506 Rabbit polyclonal
MAP2 HM-2 Mouse monoclonal
NR1 subunit residues 834e938 NR-1, CT Mouse monoclonal
PSD-95 7E3-1B8 Mouse monoclonal
Rab7 H-50 Rabbit polyclonal
Synaptophysin residues 221e313 H-8 Mouse monoclonal
*From Richard J. Kascsak (New York State Institute for Basic Research, Staten
APP, amyloid precursor protein; EEA1, early endosomal antigen 1; GFAP, glial ﬁbrilla
immunohistochemistry; MAP2, microtubule-associated protein 2; PSD-95, postsynap
1752KO line, ApoE KO mice were doubled crossed with APPSW/
PS1dE9 mice (line 85, stock number 004462; The Jackson
Laboratory, Bar Harbor, ME). In APPSW/PS1dE9 mice, the
mouse amyloid precursor protein (APP) harboring the human
Ab sequence with the double Swedish familial AD mutation
K594M/N595L and human presenilin 1 (PS1) with exon 9
deletion (dE9) are expressed under the control of the mouse
prion protein promoter and transmitted as a single Mendelian
locus. APPSW/PS1dE9/ApoE KO founders were identiﬁed by
PCR on MyiQ2 real-time PCR system (Bio-Rad, Hercules,
CA) by using pairs of primers for PS1 transgene (50-TA-
AGTCAGTCAGCTTTTATACCCGGAAGGA-30 and 50-
CAGGAGGATAGTCATGACAACAATGACACT-30) and
by showing lack of PCR product with APOE primers (50-
AGACGCGGGCACGGCTGT-30 and 50-CTCGCGGAT-
GGCGCTGAG-30). APPSW/PS1dE9/ApoE KO mice were
then crossed back several times with ApoE-TR mice that
carried one of the three human alleles (APOE2, APOE3, or
APOE4) until the expression of APPSW/PS1dE9 transgene on
the homozygote background of each of the three humanApoE
isoformswas established. EachApoE-TRmouse line contains
mouse regulatory sequences and the noncoding murine exon
1 surrounding the inserted human exons 20, 30, and 40.18,19
Therefore, these mice express the human ApoE protein at
physiological levels and retain the endogenous regulatory
sequences required for modulating ApoE expression. APPSW/
PS1dE9/ApoE-TR lines were maintained by breeding with
ApoE isoform-matched ApoE-TR mice. Offspring wereDilution
SourceIC/IH WI/DI
1:1000 1:5000 Gift*
1:1000 1:5000 Gift*
1:1000 Washington University in St. Louis, MO
1:1000 Washington University in St. Louis
1:2500 Washington University in St. Louis
1:500 Invitrogen
1:1000 Washington University in St. Louis
1:1000 Millipore Corporation, Billerica, MA
1:1000 Sigma-Aldrich
1:2000 Sigma-Aldrich
1:1000 Sigma-Aldrich
1:100 Santa Cruz Biotechnology, Santa Cruz, CA
1:100 Santa Cruz Biotechnology
1:100 Stressgen Bioreagents, Ann Arbor, MI
1:1000 Sigma-Aldrich
1:2000 Dako North America Inc., Carpinteria, CA
1:1000 Sigma-Aldrich
1:100 Millipore Corporation
1:500 Millipore Corporation
1:100 Santa Cruz Biotechnology
1:200 Santa Cruz Biotechnology
Island, NY).
ry acidic protein; HSP60, heat shock protein 60; IC/IH-immunocytochemistry/
tic density protein 95; WI/DI Western immunoblotting/dot immunoblotting.
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Ab12-28P Reduces Intraneuronal Abidentiﬁed by PCR. The human ApoE isoform status was
veriﬁed by restriction fragment length polymorphism analysis
of the human APOE gene PCR product.20 Animals were bred
and housed in a germ-free facility with 12/12-hour light/dark
cycle and ad libitum food and water access. Given docu-
mented sex differences in Ab deposition in the APPSW/
PS1dE9 strain,
21 the load of Ab plaques and intraneuronal Ab
accumulation were quantiﬁed only in female mice. All mice
that were compared were on the same genetic background.
Handling of Synthetic Ab Peptides
Ab peptides were synthesized on solid-phase support and
puriﬁed by reverse-phase high-pressure liquid chromatog-
raphy, as previously described.16,22 Full-length sequences of
Ab1-40, Ab1-42, and Ab1-40 amino-terminally tagged with
5,6-carboxyﬂuorescein (FITC-Ab1-40) were synthesized
with L-amino acids, whereas end-protected Ab12-28P
(NH2-VHHQKLPFFAEDVGSNK-COOH) and its scram-
bled version Ab12-28PS (NH2-QGKFSDHVNEPHFAVKL-
COOH) were synthesized with D-amino acids as previously
described.16,22 The purity of each batch of peptides was
veriﬁed by mass spectrometry. Ab peptides were treated with
1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFIP), which renders
peptides monomeric with minimal b-sheet content,4,16 and
lyophilized. Lyophilized aliquots of Ab peptides were stored
at 80C. Immediately before commencing cell culture
experiments, Ab peptides were directly reconstituted in cell
culture media to achieve the concentration used in particular
experiments.
Ab oligomers were prepared according to established
protocols4,23,24 by incubating 100 mmol/L Ab1-42 in serum
and phenol-free Dulbecco’s modiﬁed Eagle’s medium
mixed 1:1 with Ham’s F12 medium, then centrifuged with
Microcon YM-10 concentrators to remove unaggregated Ab
monomers.
Cell Culture Preparation
Cultures of primary hippocampal neurons and astrocytes were
established from pups within 24 hours from birth (P0 to P1).
Animals were sacriﬁced by decapitation, and their brains were
immediately removed from skulls in aseptic conditions. To
establish cultures of primary hippocampal neurons, the hippo-
campi were dissected from both hemispheres under AmScope
stereoscopic microscope (AmScope, Chino, CA). Fragments of
hippocampal tissuewere placed in the ice-coldHank’s balanced
salt solution free of Ca2þ and Mg2þ and gently cut further into
ﬁne pieces that were then treated with 0.05% trypsin in Hank’s
balanced salt solution for 10 minutes at 37C to obtain cell
suspension.After the addition of 0.1% type-I-S trypsin inhibitor
and 0.05% DNase I, the cell suspension was centrifuged at 500
 g for 30 seconds. The resulting pellet was triturated, centri-
fuged again at 500  g for 5 minutes, and resuspended in the
minimal essential medium (MEM) supplemented with heat-
inactivated 10% fetal bovine serum (FBS), 0.5 mmol/LThe American Journal of Pathology - ajp.amjpathol.orgglutamine, 50 mg/mL streptomycin, and 50 U/mL penicillin.
Cell suspension was then ﬁltered through a 70-mm mesh, and
the neurons were manually counted with the use of a hemoto-
cytometer (Hausser Scientiﬁc, Horsham, PA) and seeded on
poly-L-lysineecoated 12-well plates. For biochemical analysis,
5  105 neurons were seeded directly on the bottom of each
well, whereas, for immunohistochemistry, removable poly-L-
lysineecoated round coverslips were placed on the bottom of
thewells, and the number of seeded neuronswas reduced to 1
105 per well. The neurons were allowed to adhere to the surface
for 4 hours, and then the medium was replaced with the serum-
free Neurobasal medium containing 2% B27 supplement, 0.5
mmol/L glutamine, 50 mg/mL streptomycin, and 50 U/mL
penicillin. At 3 days in vitro (DIV), 5 mmol/L cytosine-b-D-
arabinoside was added to inhibit division of nonneuronal cells.
The neurons were fed by replacing one-third of the medium
volume every 72 hours. At 7 DIV, one well from each prepa-
ration of primary hippocampal neurons was randomly selected
to determine the purity of the culture and was immunostained
against a neuronal-speciﬁc marker, the microtubule-associated
protein 2 (MAP2), followed by nucleic acid stain DAPI
(Figure 1C). The ratio ofMAP2-positive to DAPI-positive cells
was then calculated to assess culture purity. Those cultures that
showed a purity of at least 90%were grown further until 14DIV
when neurons reach their mature form and express functional
glutamatergic receptors.25
Cultures of astrocytes were established from the brain
cortex according to the protocol of Leroux et al.26 After
stripping the brain from themeninges andvisible brain vessels,
the cortical mantle was separated from the white matter and
subcortical structures and gently cut intoﬁne pieces in ice-cold
Hank’s balanced salt solution free of Ca2þ and Mg2þ. Cell
suspensionwas prepared by gentle trituration of cortical tissue
and then centrifuged for 5 minutes at 500 g. The pellet was
resuspended inMEMsupplementedwith 20%FBS, 2mmol/L
glutamine, 50 mg/mL streptomycin, and 50 U/mL penicillin,
and the cells were introduced to 25-cm2 ﬂasks. Two days after
establishing the astrocytic culture, a single dose of 5 mmol/L
cytosine-b-D-arabinoside was added. After 6 days of growth,
the FBS content in MEM was decreased to 10%, and astro-
cytes were grown until conﬂuence. To determine the purity of
the astrocytic cultures, the cells were seeded on a coverslip,
ﬁxed with methanol, and immunostained against glial ﬁbril-
lary acidic protein and counterstained with DAPI. Cultures
containing 90% or more glial ﬁbrillary acidic protein-positive
astrocytes were used for co-culture experiments (Figure 1B).
Production of ApoE by astrocytes was conﬁrmed with
Western immunoblot analysis with HJ6.1 mAb against
murine ApoE in astrocytic lysates and media (Figure 1D).
To set up the neuronal-astrocytic co-culture system,
astrocytes were harvested with the use of 0.25% trypsin and
0.03% EDTA, suspended in MEM with 10% FBS, and
counted with the use of a hemocytometer. Astrocytes were
then plated on the top side of the poly-L-lysineecoated pol-
ycarbonate membranes of the Transwell inserts27 (2 104 per
insert) and cultured in MEM supplemented by 10% FBS,1753
Kuszczyk et al2 mmol/L glutamine, 50 mg/mL streptomycin, and 50 U/mL
penicillin for 48 hours followed by serum-free Neurobasal
mediumsupplementedwith2%B27and0.5mmol/Lglutamine
for 24 hours before combining the cultures. Transwell inserts
with attachedastrocyteswere transferred into12-well plates and
positioned 2mmabove the neuronalmonolayer growing on the
bottom of the well (Figure 1A). Pores in the polycarbonate
membranes of the Transwell insert allow for free passage of
astrocyte-derived molecules, including lipidated ApoE com-
plexes. The co-culture was maintained together in serum-free
Neurobasal medium supplemented with 2% B27, 0.5 mmol/L
glutamine, 50 mg/mL streptomycin, and 50U/mL penicillin for
24 hours before commencing experiments. The astrocyteswere
always combined with neurons when neurons were 14 DIV,
and the co-culture experimentswere commencedwhenneurons
were 15 DIV. The ApoE uptake by the primary hippocampal
neurons was conﬁrmed by Western immunoblot detection of
ApoE in lysates from neurons co-cultured with astrocytes,
whereas in the lysates of primary hippocampal neurons grown
as a monoculture the ApoE signal was absent (Figure 1D).
Treatments of Neuronal Monocultures and Co-Culture
Systems with Ab Peptides
Monomerized Ab1-40 and Ab1-42 peptides were diluted with
the Neurobasal medium to 10 mmol/L ﬁnal concentration and
added without or with 10 mmol/L Ab12-28P or a control
peptide Ab12-28PS to neuronal-astrocytic co-cultures or neu-
ronal monocultures for 24 or 72 hours. In confocal microscopy
experiments designed to directly visualize intraneuronal Ab
accumulation, Ab1-40 was traced with 10% FITC-Ab1-40. In
the experiment designed to investigate the effect of ApoE on
intraneuronal degradation of internalized Ab, 10 mmol/L Ab1-
40was added to themedium for 6 hours, and then the cells were
further grown in theAb-freemediumduring the 48-hourwashout
period. At the conclusion of each experiment, co-cultures were
disassembled by removing Transwell inserts with attached
astrocytes, and the primary hippocampal neurons grown on the
bottom of the well were subjected to lysis or ﬁxation for
biochemical or immunohistochemical analyses, respectively.
Each treatment experiment in neuronal-astrocytic co-cultures
or neuronal monocultures was repeated three to six times.
Western Blot and Dot Immunoblot Analysis
Primary hippocampal neurons were washed three times with
PBS at 37C and gently treated with 0.1% trypsin and 0.03%
ethylenediaminetetraacetic acid in PBS to remove remnants
of noninternalized Ab attached to their external surfaces.28
Neurons were then harvested with ice-cold lysis buffer that
contained 50mmol/L Tris-HCl, pH 7.4, 150 mmol/L NaCl, 1
mmol/L ethylenediaminetetraacetic acid, 1% Nonidet-
P40, 0.1% SDS, 0.2% diethylamine, 1 mmol/L phenyl-
methylsulfonyl ﬂuoride, 10 mg/mL Complete Protease
Inhibitor Cocktail supplemented with leupeptin, antipain,
and pepstatin (5 mg/mL each).22 The lysates were collected1754into 2-mL low-adhesion tubes, further homogenized with 10
strokes of a Teﬂon pestle, and centrifuged at 10,000  g for
20 minutes at 4C. The pellets containing cell debris were
discarded, and the total protein concentration in the super-
natant ﬂuid was determined with the bicinchoninic acid
assay. Samples of cell lysates that contained equal amounts of
total protein were titrated with reducing Laemmli buffer to
achieve equal volumes, boiled for 5 minutes, and then sub-
jected to SDS-PAGE with the use of 15% gels. Under afore-
described reducing conditions, most Ab contained in the cell
lysates appeared asmonomers and dimers at the bottomof the
membrane, which facilitated its densitometric quantiﬁcation
(Supplemental Figure S1, A and B). After Western blot
transfer, nitrocellulosemembraneswere immunoblottedwith
1:1 mixture of 6E10 and 4G8 mAbs29 followed by horse-
radish peroxidase-conjugated sheep anti-mouse secondary
Ab in 1:3000 dilution and the application of SuperSignal
chemiluminescent reagent. To assure that Ab12-28P, which
has sequence overlap with the 4G8 epitope, does not alter
4G8 signal, a control experiment was conducted whereby
synthetic Ab1-40 or Ab1-42 peptides were loaded on the gel
alone or premixed with Ab12-28P, and the membranes were
immunoblotted with the 6E10/4G8 mixture, 6E10, and 4G8
alone, and mAbs HJ2 and HJ7.4, which are speciﬁc for C-
termini of AbX-40 and AbX-42 peptides,
30 respectively
(Supplemental Figure S2A). There was no evidence that
Ab12-28P changes detectability of Ab1-40 or Ab1-42 
6E10 and 4G8, whereas Ab12-28P alone was unrecognized
by these mAbs. Furthermore, selected membranes that rep-
resented various treatment conditions were stripped and
reprobed with Ab C-terminalespeciﬁc mAbs that obtained
a pattern of immunostaining comparable with that of the
6E10/4G8 mixture (Supplemental Figure S2B).
For detection of ApoE in lysates of primary hippocampal
neurons and astrocytes and in the conditioned media, the
samples were subjected to 10% SDS-PAGE under reducing
conditions, and the membranes underwent immunoblot
analysis with HJ6.1 mAb. For dot blot detection of Ab
oligomers, samples of neuronal lysates that contained equal
amounts of total protein were titrated with PBS to achieve
equal volumes of 20 mL and were blotted under vacuum onto
polyvinylidene diﬂuoride membranes. The membranes were
immunoblotted with A11 oligomer-speciﬁc polyclonal Ab.31
Samples that contained preparations of HFIP monomerized
Ab1-42 and in vitro oligomerized Ab1-42 were used as
negative and positive controls, respectively. Lysates from 15-
DIV primary hippocampal neurons cultured in the absence of
Ab peptides, astrocytes, and human recombinant ApoE4
were used as additional controls (Supplemental Figure S2C).
Densitometric Analysis of Immunoblots
Autoradiography ﬁlms were converted into 8-bit grayscale
digital ﬁles with the use of a Epson Perfection 4990 scanner
(Epson America, Long Beach, CA) and Adobe Photoshop
version CS4 (Adobe Systems, San Jose, CA) and saved inajp.amjpathol.org - The American Journal of Pathology
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analysis of Ab Western and dot blot signals was performed
with NIH Image J software version 1.42 (Bethesda, MD) as
previously described.32,33Quantiﬁcation of Ab Oligomers by ELISA
Samples of neuronal lysates that contained 15 mg of total
protein were titrated with PBS to achieve equal volumes.
Concentration of Ab oligomers in the lysate samples was
determined with Human Aggregated b-Amyloid ELISA
Kit, following the manufacturer-provided manual. After
background subtraction, absorbance values from serially
diluted samples of aggregated Ab provided by the manu-
facturer as a part of the ELISA kit were used to generate
a standard curve in GraphPad Prism version 5.02 (GraphPad
Software, Inc., San Diego, CA) with the use of a nonlinear
curve-ﬁtting algorithm. Concentration of Ab oligomers in
samples of neuronal lysates was determined by comparing
their absorbance values against the standard curve and were
given in nanograms per milligram of the total protein in the
lysate.Immunocytochemistry and Quantiﬁcation of Synaptic
Protein Expression
Coverslips with attached primary hippocampal neurons
were immersed three times in PBS at 37C, then in 80% ice-
cold methanol for 10 minutes to ﬁx the neurons, and washed
again three times in PBS. Nonspeciﬁc bindings of the
primary Abs and streptavidin were blocked with MOM
blocking mixture for 1 hour, followed by the streptavidin/
biotin blocking kit for 30 minutes. Intraneuronal organelles
were identiﬁed with a panel of Abs against organelle-speciﬁc
markers: MAP2 for the cytoskeleton, early endosomal
antigen 1 for early endosomes, Rab7 for late endosomes,
Cathepsin D for late endosomes and lysosomes, and heat
shock protein 60 for mitochondria (Table 1). Synaptic
proteins speciﬁc for excitatory glutamatergic synapses of
primary hippocampal neurons, including the NR1 subunit
of the N-methyl-D-aspartic acid receptor (NMDAR), post-
synaptic density protein 95 (PSD-95), which is functionally
and structurally associated with NMDARs, and a major
synaptic vesicle protein synaptophysin were immunode-
tected with the use of speciﬁc mAbs listed in Table 1. We
used 1:1000 biotinylated secondary Abs followed by 1:500
cyanine 3-conjugated streptavidin to detect binding of
primary Abs to their antigens. Neuronal nuclei were
counterstained with DAPI. Immunostained neurons were
analyzed with an 80i Nikon ﬂuorescent microscope (Nikon
Corp., Tokyo, Japan). Negative controls for immunocyto-
chemistry included primary hippocampal neurons immu-
nostained with anti-rabbit and anti-mouse biotinylated
secondary antibodies with omission of the primary anti-
bodies (Supplemental Figure S3A) and astrocytic culturesThe American Journal of Pathology - ajp.amjpathol.orgimmunostained with mAbs for NR1, PSD-95, and syn-
aptophysin (Supplemental Figure S3B).
To determine the expression of the synaptic proteins, at
least 20 neurons from each treatment group per experiment
from three independent experiments were photographed with
the use of 100 immersion oil objective. The images were
captured with a high-sensitivity, cooled, monochrome DS-
Qi1Mc camera and NIS Elements Imaging Software version
3.01 (Nikon Corp.) and saved in a TIFF format with a reso-
lution of 600 dpi. With the use of NIH ImageJ software
version 1.42, ﬁve rectangular test areas that measured 20 4
mmol/L each were randomly superimposed along the primary
and secondary dendrites of each examined neuron, with the
long axis of the test area oriented parallel to the long axis of
the dendrites. Synaptic densities within the test area were
automatically thresholded and ﬁltered according to the
preset algorithm to discriminate nonspeciﬁc staining. Data
were expressed as the percentage values, using as 100% the
average from the total area of synaptic protein puncta per test
ﬁeld in DIV-matched control primary hippocampal neurons.
Subcellular localization of internalized Ab was examined
by two- or three-channel confocal microscopy. Serial Z stacks
of 0.5 mm thick tomograms were collected simultaneously in
ﬂuorescein and rhodamine channels with the use of a Bio-Rad
Radiance 2000 confocal system mounted on the Olympus
BX50WI ﬂuorescence microscope (Olympus America Inc.,
Center Valley, PA). Zeiss LSM510 confocal microscope (Carl
Zeiss Microscopy GmbH, Jena, Germany) was used to collect
Z stacks of 0.2 mm thick tomograms in ﬂuorescein, rhodamine,
and Texas Red channels. Captured stacks of images were
further analyzed with Zeiss LSM Image Browser software
version 4.2.0.121 or NIH ImageJ software version 1.42.Histology, Immunohistochemistry, and Quantitative
Analysis of Ab Plaque Load and Intraneuronal Ab
Accumulation in APPSW/PS1dE9/ApoE KO and
APPSW/PS1dE9/ApoE-TR Tg Mice
Eleven-month-old female Tg mice were sacriﬁced with an
intraperitoneal injection of 150 mg/kg sodium pentobarbital
and transcardially perfused with heparinized PBS. Brains
were ﬁxed by immersion in 4% paraformaldehyde in 0.1
phosphate buffer, pH 7.4, for 48 hours. Brains were dehy-
drated in a mixture of 20% glycerol and 20% dimethyl
sulfoxide in PBS for 72 hours and cut into 40-mmethick
coronal sections on a freezing microtome. Serial sections
were collected in 10 separate series, each containing every
tenth section cut along the rostrocaudal brain axis.
Randomly selected series were stained with thioﬂavine-S,22
and X-34 dye21 for ﬁbrillar Ab deposits and immunostained
with HJ3.4 monoclonal Ab,21 followed by MOM peroxidase
kit to visualize the full spectrum of extracellular Ab deposits
containing its ﬁbrillar and nonﬁbrillar forms. Negative
controls for HJ3.4 immunohistochemistry included sections
from C57BL/6 mice and sections from APPSW/PS1dE9/1755
Kuszczyk et alApoE4 mice immunostained with omission of HJ3.4
(Supplemental Figure S3C). The Ab plaque load in the
neocortex (percentage of cross-sectional area covered by
Ab) was quantiﬁed on X-34-stained sections in a blinded
manner according to unbiased stereologic principles (Cav-
alieri-point counting method) as previously published.21
For the analysis and quantiﬁcation of intraneuronal Ab
accumulation, brains were embedded in parafﬁn and cut into
10-mmethick coronal sections, which were mounted on glass
slides. After deparafﬁnization, sections were washed three
times in PBS, and nonspeciﬁc bindings of the primary Abs
and streptavidin were blocked with MOM blocking mixture
for 1 hour, followed by the avidin/biotin blocking kit for 30
minutes. 6E10/4G8 mAb mixture was then added for 2 hours
followed by 1:1000 biotinylated goat anti-mouse IgG
secondary Ab for 1 hour and 1:500 FITC-conjugated strep-
tavidin for 30 minutes. MOM blocking mixture was applied
again for 1 hour, followed by anti-MAP2 Ab and cyanine 3-
conjugated sheep anti-mouse secondary Ab. Vigorous
washing was performed between each step of double
immunoﬂuorescence staining. The sections were analyzed
under Bio-Rad Radiance 2000 confocal system mounted on
the Olympus BX50WI ﬂuorescence microscope. Ten stacks
of confocal images spanning the entire thickness of the
pyramidal layer of the CA1 and CA2/3 cornu ammonis
sectors per section were taken from ﬁve to seven serial
sections per brain. Neurons positive for intraneuronal Ab1-X
were identiﬁed only as those which were displaying bright
punctuate immunostaining pattern inside the perikaryon, but
not those showing weak, diffuse membrane staining. The
number of neurons positive for intraneuronal Ab1-X against
the total number of neurons visualized by anti-MAP2
neuronal cytoskeletal staining was quantiﬁed and averaged
per hippocampal sector in a given mouse brain. Additional
hippocampal sections were immunostained with antibodies
against C-terminus of AbX-42, and amino and carboxy
termini of APP, followed by DAPI counterstaining to control
for the speciﬁcity of 6E10/4G8 immunostaining and the
effect of ApoE KO on APP expression. Negative control for
immunohistochemistry included hippocampal sections from
C57BL/6 mice immunostained with anti-Ab and anti-APP
Abs (Supplemental Figure S3D).
Statistical Analysis
The statistical analysis was performed with GraphPad Prism
version 5.02 (GraphPad Software, Inc.). Differences in the
levels of the intraneuronal Ab and expression of synaptic
proteins were analyzed using repeated measures one-way
analysis of variance followed by the Tukey’s HSD post hoc
test. Two-way analysis of variance followed by Bonferro-
ni’s post hoc test was used to analyze differences in the
number of hippocampal neurons with intraneuronal Ab
deposits between CA1 and CA2/3 hippocampal sectors and
between APPSW/PSdE9/ApoE KO and various APPSW/
PSdE9/ApoE-TR lines. The U-test was used to analyze the1756therapeutic effect of Ab12-28P in co-culture system on the
intraneuronal Ab oligomer level and differences in the load
ﬁbrillar Ab deposits between various APPSWPS1dE9/ApoE-
TR lines.
Results
Primary Hippocampal Neurons Co-Cultured with
Astrocytes Show Increased Intraneuronal
Accumulation of Ab Peptides, Which Can Be Reduced
with the ApoE/Ab Binding Antagonist Ab12-28P
Uptake of Ab1-40 and Ab1-42 from the conditioned media
and their intraneuronal accumulation was compared between
the primary hippocampal neurons cultured alone and the
primary hippocampal neurons co-cultured with astrocytes
combined in a noncontact neuronal-astrocytic co-culture
system (Figure 1). In this in vitro experimental system,
synthetic Ab1-40 or Ab1-42 peptides monomerized by HFIP
treatment were added to the culture media once at the com-
mencement of the experiment in the ﬁnal concentration of 10
mmol/L.Both theprimary hippocampal neurons and astrocytes
(unless speciﬁcally stated otherwise) were derived from
C57BL/6 wild-type mice. We also conﬁrmed that neurons co-
cultured with astrocytes internalize ApoE secreted by astro-
cytes to the conditioned media. This was done by Western
immunoblot detection of ApoE in lysates of neurons co-
cultured with astrocytes, whereas in the lysates of neurons
cultured alone the ApoE signal was absent (Figure 1D).
Shown in Figure 2, A and B, are comparisons of intra-
neuronal levels of Ab1-40 and Ab1-42 between primary
hippocampal neurons cultured alone or co-cultured with
astrocytes for 24 hours in the presence of Ab1-40 and
Ab1-42 peptides, respectively. Although the primary
hippocampal neurons cultured alone showed internalization
of Ab1-40 and Ab1-42 peptides from the media, the intra-
neuronal accumulation of both Ab peptides was signiﬁ-
cantly increased in neurons, co-cultured with astrocytes. The
intraneuronal level of Ab1-40 in neurons from neuronal-
astrocytic co-cultures was at 150.8%  3.6% (means 
SEM) of the level of neurons cultured alone (P < 0.001)
(Figure 2A and Supplemental Figure S1A), whereas the
level of Ab1-42 was at 227.1%  26.4% of the level
of neurons grown alone (P < 0.01) (Figure 2B and
Supplemental Figures S1B and S2B). When Ab12-28P, the
antagonist of the ApoE/Ab interaction, was added to the
culture media together with Ab1-40 and Ab1-42 at the
commencement of the experiment (10 mmol/L ﬁnal
concentration), intraneuronal levels of Ab1-40 and Ab1-42
peptides were reduced to 46.6%  4.8% (P < 0.001) and
82.8%  9.0%, respectively (P < 0.01), of those in neurons
cultured alone. Ab12-28PS, a control peptide that represents
a scrambled sequence of Ab12-28P, had no signiﬁcant
effect on intraneuronal levels of Ab1-40 and Ab1-42
peptides in primary hippocampal neurons co-cultured with
astrocytes. Moreover, Ab12-28P had no effect on theajp.amjpathol.org - The American Journal of Pathology
Figure 2 Western immunoblot analysis of the intraneuronal Ab1-40 and Ab1-42 content. A and B: Representative immunoblots for Ab1-40 and Ab1-42 in
lysates of primary hippocampal neurons, respectively. Lanes 1, 2, 3 and 7 represent primary hippocampal neurons cultured alone, whereas lanes 4, 5, and 6
represent primary hippocampal neurons co-cultured with astrocytes. Exposure to Ab1-40 and Ab1-42 and cotreatment with Ab12-28P and Ab12-28PS are
indicated directly underneath each lane. Samples containing 10 mg and 5 mg of total protein per lane were loaded in A and B, respectively. The full Western
immunoblot analyses are provided in Supplemental Figure S1. Included are also Western immunoblot analyses for b-actin, which was used as a loading control.
Values in the graphs show the mean percentage SEM of Ab1-40 and Ab1-42 band optic densities relative to those in neurons cultured alone during exposure to
Ab peptides (lane 2) in ﬁve and four independent experiments that used Ab1-40 (analysis of variance P< 0.0001) and Ab1-42 (analysis of variance PZ 0.0006),
respectively. Values of post hoc pair analysis obtained with Tukey’s HSD test are displayed on the graph if statistically signiﬁcant. C: Western immunoblot analysis
for ApoE in the conditionedmedia of neuronal-astrocytic co-cultures under various Ab1-42 and Ab12-28P treatment conditions (lanes 2e5). Samples of the
conditioned media from primary hippocampal neurons cultured alone (lane 1) and high-density astrocytic monoculture grown in the cell culture ﬂask (lane 7) are
shown as a negative and a positive control, respectively. Lane 6 was intentionally left unloaded. Values in the graph show the mean percentage  SEM of ApoE
band optic densities relative to those in neuronal-astrocytic co-cultures maintained without addition of any Ab peptides in three independent experiments
(analysis of variance PZ 0.17). D: Immunoblot for Ab1-42 in lysates of primary hippocampal neurons cultured alone (lane 1) and primary hippocampal neurons
co-cultured with ApoE KO astrocytes without or with cotreatment with Ab12-28P (lanes 2 and 3, respectively). Included is also Western immunoblot analyses for
b-actin, which was used as a loading control. Values in the graph show the mean percentage SEM of Ab1-42 band optic densities relative to those in neurons
cultured alone during exposure to Ab1-42 in three independent experiments (analysis of variance PZ 0.53). *P < 0.05, **P < 0.01, and ***P < 0.001.
Ab12-28P Reduces Intraneuronal Abintraneuronal level of Ab peptides, when it was added to
primary hippocampal neurons cultured alone in the presence
of Ab1-40 or Ab1-42 peptides. No signiﬁcant differences
were observed in the ApoE level in the conditioned media
among various experimental conditions, which could
account for the differences in the intraneuronal levels of Ab
peptides (Figure 2C).
To conﬁrm that the increased intraneuronal accumulation
of Ab peptides in neurons co-cultured with astrocytes was
directly related to astrocyte-secreted ApoE, we conducted a
control experiment in which neuronal-astrocytic co-cultures
were set up from primary hippocampal neurons derived from
C57BL/6 wild-type mice and astrocytes derived from ApoE
KO mice, which were on the C57BL/6 background. Con-
centrations and length of exposure to Ab1-42 and Ab12-28P
were exactly matching the conditions in experiments with
neuronal-astrocytic co-cultures that used wild-type astro-
cytes. No statistically signiﬁcant differences in the intra-
neuronal Ab1-42 level were appreciated between primary
hippocampal neurons cultured alone and those co-cultured
with ApoE KO astrocytes. Ab1-42 level in neurons co-
cultured with ApoE KO astrocytes was at 87.8%  6.8% of
the Ab1-42 level of neurons cultured alone, whereas, in
neurons co-cultured with astrocytes and additionally treated
with Ab12-28P, the intraneuronal Ab1-42 level was at 93.0%
 10.9% of the Ab1-42 level of neurons cultured alone
(differences statistically not signiﬁcant) (Figure 2D).The American Journal of Pathology - ajp.amjpathol.orgFurthermore, we investigated whether co-culturing of
neurons with astrocytes affected intraneuronal level of Ab
oligomeric assemblies as well as the rate of intraneuronal
degradation of internalized Ab. Two independent methods
were used to characterize intraneuronal content of Ab
oligomers, namely a dot immunoblot analysis that used A11
oligomer-speciﬁc Ab and ELISA speciﬁc for human-
aggregated Ab. We saw 11.8- and 1.7-fold increase (P <
0.001) in the level of intraneuronal Ab1-40 and Ab1-42
oligomers in primary hippocampal neurons co-cultured with
astrocytes compared with those cultured alone, respectively
(Figure 3A). Note that the primary hippocampal neurons
cultured alone showed an approximately sevenfold greater
level of intraneuronal Ab1-42 oligomers than Ab1-40
oligomers (P < 0.001), whereas no statistically signiﬁcant
difference between Ab1-42 and Ab1-40 oligomer levels
was noted in neurons co-cultured with astrocytes. This
observation indicated that ApoE more effectively promotes
oligomerization of Ab1-40, which has weaker self-
aggregation properties than Ab1-42, which is inherently
more prone to form oligomers. The treatment of primary
hippocampal neurons co-cultured with astrocytes with
Ab12-28P, which was added to the culture media together
with Ab1-40 and Ab1-42 at the commencement of the
experiment, produced a signiﬁcant reduction in the intra-
neuronal Ab oligomer level. The concentration of intra-
neuronal Ab1-40 oligomers in neurons from untreated1757
Kuszczyk et alco-cultures was 57.5  8.3 ng/mg, whereas under Ab12-28P
treatment it was reduced to 30.0  6.3 ng/mg (P < 0.05) as
determined by ELISA speciﬁc for aggregated Ab. The
concentration of Ab1-42 oligomers was 57.5  5.9 ng/mg,
whereas under Ab12-28P treatment it was reduced to
40.0  6.3 ng/mg (P < 0.05) (Figure 3B).
The effect of ApoE on the intraneuronal degradation of
internalized Ab was investigated by comparing how effec-
tively primary hippocampal neurons cultured alone and
those co-cultured with astrocytes degraded Ab1-40 inter-
nalized during time-limited exposure (Figure 4, A and B).
Neuronal monocultures and neuronal-astrocytic co-cultures
were exposed to monomerized, synthetic Ab1-40 peptide
for 6 hours (10 mmol/L ﬁnal concentration in the condi-
tioned media at the commencement of the experiment), then
the conditioned media were replaced with Ab1-40efree
media, and neurons were grown further in monoculture or
in co-culture with astrocytes (washout period). Primary
hippocampal neuron culture alone degraded 50% of the
internalized Ab1-40 within 3.2 hours, and no Ab1-40 was
detectable in their lysates at 24 hours after the commence-
ment of the washout period. In contrast, the primary
hippocampal neurons co-cultured with astrocytes still
showed the presence of intraneuronal Ab1-40 at 24 and 48
hours after the commencement of the washout period, which
was 43.7%  4.9% and 32.9%  9.2%, respectively, of the
Ab1-40 signal at t Z 0 hours.
We also analyzed the levels of Ab1-40 and Ab1-42
peptides in the conditioned media of the primary hippo-
campal neurons cultured alone and in the conditioned media
of neuronal-astrocytic co-cultures (Supplemental Figure S4,
A and B). We noted that at the conclusion of the experi-
ment, a signiﬁcant reduction was seen in the levels of both
Ab1-40 and Ab1-42 peptides in the conditioned media from
neuronal-astrocytic co-cultures compared with the levels of
Ab peptides in the conditioned media from neuronal
monocultures. This effect was likely caused by the active
clearance of Ab peptides from the media by astrocytes. ToFigure 3 Analysis of intraneuronal content of Ab oligomers. A: Representative
from lysates of primary hippocampal neurons cultured alone and those co-cultured
show the mean dot blot optic densities  SEM in four independent experiments (
conducted with Tukey’s HSD test are displayed on the graph if statistically signiﬁ
hippocampal neurons co-cultured with astrocytes without or with Ab12-28P treatm
in nanograms of Ab per milligram of the total protein in cell lysate. Values are give
to analyze statistical signiﬁcance of the Ab12-28P treatment separately for Ab1-
1758conﬁrm that astrocytes can robustly clear Ab peptides from
the conditioned media, we conducted a complementary
experiment in which monomerized, synthetic Ab1-40 or
Ab1-42 peptides were added to the media of astrocytes
cultured alone (10 mmol/L ﬁnal concentration at tZ 0 hours),
and then changes in the level of Ab peptides in the media
were analyzed over time. At tZ 24 hours levels of Ab1-40
and Ab1-42 were reduced by 30.8%  6.3% and 24.4% 
4.9%, respectively, compared with the levels of Ab peptides
at tZ 0 hours, whereas at tZ 96 hours levels of Ab1-40 and
Ab1-42 were reduced by 68.2%  2.7% and 49.4  0.9%,
respectively (two-way analysis of variance P < 0.0001
for the effect of Ab1-40 versus Ab1-42) (Supplemental
Figure S4C).
Furthermore, we analyzed the rate of intracellular
degradation of internalized Ab by astrocytes akin to the
experiment in which we compared the rate of intraneuronal
degradation of Ab between primary hippocampal neurons
cultured alone and those co-cultured with astrocytes. After 6
hours of exposure to 10 mmol/L Ab1-40, the Ab1-40 signal
was seen only in the astrocytic lysate at the conclusion of
the Ab exposure, whereas no Ab1-40 signal was detectable
within t Z 2 hours after commencement of the washout
period (Supplemental Figure S4D). These experiments
conﬁrmed robust Ab clearance and intracellular degradation
capacity of astrocytes.Confocal Microscopy Analysis of Ab1-40 Accumulation
and Distribution in the Primary Hippocampal Neurons
Cultured Alone and Those Co-Cultured with Astrocytes
without and with Ab12-28P Treatment
Along with biochemical analysis of the intracellular Ab
content, we have used confocal microscopy to directly
image differences in the intracellular accumulation and
distribution of Ab between primary hippocampal neurons
cultured alone and those co-cultured with astrocytes. In thedot immunoblots developed with the use of A11 oligomer-speciﬁc antibody
with astrocytes, after exposure to Ab1-40 and Ab1-42. Values in the graphs
one-way analysis of variance P < 0.0001). Values of post hoc pair analysis
cant. B: Levels of intraneuronal Ab1-40 and Ab1-42 oligomers in primary
ent quantiﬁed with ELISA speciﬁc for aggregated human Ab and expressed
n as means  SEM from ﬁve independent experiments. The U-test was used
40 and Ab1-42. *P < 0.05, ***P < 0.001.
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Figure 4 Intraneuronal degradation of internalized Ab1-40. A: Repre-
sentative Western immunoblot analysis for Ab1-40 in lysates of primary
hippocampal neurons cultured alone (top panel) and co-cultured with
astrocytes (bottom panel) at various time points during the washout
period after 6 hours of exposure to Ab1-40; densitometric analysis is
depicted in B. Also included are Western immunoblot analyses for b-actin,
which was used as a loading control. B: Intraneuronal levels of Ab1-40
during the washout period. Data expressed as the mean percentage  SEM
of Ab band optic densities relative to those at tZ 0 hours (conclusion of
the exposure to Ab1-40) from ﬁve independent experiments.
Ab12-28P Reduces Intraneuronal Abconfocal microscopy experiments, Ab1-40 added to the
culture medium was traced with 10% FITC-Ab1-40, which
allowed us to directly visualized Ab accumulation and
distribution. The Ab1-40/FITC-Ab1-40 mixture was added
to the conditioned media once at the commencement of theThe American Journal of Pathology - ajp.amjpathol.orgexperiment at the ﬁnal concentration of 10 mmol/L, and the
neurons were cultured in its presence for 72 hours. In
primary hippocampal neurons cultured alone, most of the
Ab1-40 was found outside neurons visible in the form of
ﬁne aggregates that covered the external surface of their
dendrites (Figure 5A). A small amount of Ab1-40 was also
found inside neuronal perikarya (Figure 5, B and C). In
contrast, in neurons co-cultured with astrocytes, a signiﬁ-
cantly smaller number of Ab1-40 aggregates were seen on
the external surface of dendrites (Figure 5D). Instead,
confocal microscopy tomograms taken at the level of peri-
karya showed large Ab1-40 aggregates present inside the
neurons. They were clearly visualized inside the perikarya
and in proximal segments of the primary dendrites
(Figure 5, E and F). Intraneuronal Ab aggregates stained
negatively with thioﬂavin-S, which indicated that they
contain no ﬁbrillar Ab (not shown). In the treatment
experiment, 10 mmol/L Ab12-28P was added together with
Ab1-40/FITC-Ab1-40 to the neuronal-astrocytic co-cultures
at the commencement of the experiment. Under Ab12-28P
treatment, the amount of intraneuronal Ab1-40 aggregates
was greatly reduced (Figure 5, GeI).
Furthermore, we combined confocal microscopy with
immunocytochemistry against organelle-speciﬁc markers
to analyze the subcellular distribution of internalized Ab1-
40 in primary hippocampal neurons when they were
cultured alone or co-cultured with astrocytes without and
with Ab12-28P treatment. As in the previous experiments,
neuronal monocultures and neuronal-astrocytic co-cultures
were maintained in the presence of Ab1-40 traced with 10%
FITC-Ab1-40 (10 mmol/L ﬁnal Ab1-40/FITC-Ab1-40
concentration) for 72 hours. At the conclusion of the
experiment, they were ﬁxed and immunostained against
early endosome antigen 1 early endosomal marker, Rab7
late endosomal marker, Cathepsin D late endosomal and
lysosomal marker, and heat shock protein 60 as a mito-
chondrial marker. Primary hippocampal neurons cultured
alone showed a modest amount of intraneuronal Ab1-40,
which colocalized weakly with all four organelle markers
(Figure 6, A and B, and Supplemental Figure S5, A and B).
In contrast neurons co-cultured with astrocytes showed
a substantial increase in the intraneuronal content of Ab1-
40 compared with neurons cultured alone. In neurons from
the neuronal-astrocytic co-cultures, the Ab1-40 content was
particularly increased in late endosomes and in lysosomes
(Figure 6C and Supplemental Figure S5C). To less extent,
Ab1-40 colocalized with markers for early endosomes and
mitochondria. Furthermore, some Ab1-40 was seen outside
the nuclear envelope and did not show colocalization with
any of the aforementioned organelle markers, which sug-
gested its possible cytoplasmic localization. As in previous
experiments, Ab12-28P treatment of primary hippocampal
neurons co-cultured with astrocytes resulted in a marked
reduction in the intraneuronal Ab accumulation in all
investigated organelles and cytoplasm (Figure 6D and
Supplemental Figure S5D).1759
Figure 5 Confocal microscopy analysis of Ab1-
40 distribution and accumulation in the primary
hippocampal neurons. A: A tomographic cross
section through the level of the dendritic tree of
a representative primary hippocampal neuron from
a monoculture grown in the presence of Ab1-40 in
the conditioned media. Ab1-40 was traced with 10%
of FITC-Ab1-40. Arrows show ﬁne Ab1-40 aggre-
gates that decorate the outer surface of the
dendrites. B and C: A tomographic cross section
through the level of the perykaryon of the same
neuron. Arrows indicate sparse intraneuronal Ab1-
40 aggregates in the perykaryon and in proximal
segments of primary dendrites. D, E, and F: A
representative primary hippocampal neuron from
a neuronal-astrocytic co-culture grown in the pres-
ence of Ab1-40/FITC-Ab1-40. Arrowheads indicate
large Ab1-40 aggregates in the perykarion and in the
proximal segments of dendrites. G, H, and I: A
representative primary hippocampal neuron grown in
co-culture with astrocytes and treated with Ab12-
28P during exposure to Ab1-40/FITC-Ab1-40,
showing a marked reduction in the intraneuronal Ab
accumulation. Neurons were identiﬁed by antie
microtubule-associated protein (MAP) 2 immuno-
staining (red) whereas green color represents FITC-
Ab1-40 ﬂuorescence. All shown confocal tomograms
are 1 mm thick. Tomograms through the perikaryon
were taken 5 to 6 mm above the level of tomograms
showing dendritic tree. Scale bars: 20 mm (A and B);
5 mm (C).
Kuszczyk et alPrimary Hippocampal Neurons Co-Cultured with
Astrocytes Show Enhanced Loss of Synaptic Proteins
During Exposure to Ab1-40, Which Can Be Inhibited by
Ab12-28P Treatment
To investigate whether increased intraneuronal accumula-
tion and oligomerization of Ab by primary hippocampal
neurons co-cultured with astrocytes is associated with
enhanced synaptic degeneration, we determined surface
expression of the following synaptic proteins: NR1 subunit
of the NMDAR, PSD-95, and synaptophysin. Quantiﬁcation
of synaptic protein expression was performed in 18-DIV
primary hippocampal neurons cultured alone or co-cultured
with astrocytes after 72 hours of exposure to Ab1-40 traced
with 10% FITC-Ab1-40 (10mmol/L ﬁnal concentration),
without and with Ab12-28P cotreatment. In primary hippo-
campal neurons cultured alone, exposure to Ab1-40 resulted
in signiﬁcant down-regulation of the NR1 subunit of
NMDAR, PSD-95, and synaptophysin expression by 46.3%,
51.9%, 54.4% of the control neuron expression, respectively
(P < 0.001) (Figure 7, A, B, and F). In primary hippocampal
neurons cultured alone, loss of synaptic proteins expression
was mainly associated with the presence of Ab1-40 aggre-
gates that covered the external surfaces of the dendrites
(Figure 7B), whereas the amount of intraneuronally accu-
mulated Ab was modest.
Co-culturing of primary hippocampal neurons with astro-
cytes in the absence of Ab1-40 was associated with marked1760up-regulation of PSD-95 and synaptophysin expression
comparedwith primary hippocampal neurons cultured alone by
21.7% and 12.2%, respectively (P< 0.001) (Figure 7, C and F),
whereas no statistically signiﬁcant difference in the expression
of NMDAR NR1 subunit was observed (Figure 7, C and F).
When primary hippocampal neurons grown in co-cultures with
astrocytes were exposed to Ab1-40, the reduction in the
synaptic protein expression was markedly greater than that
observed in primary hippocampal neurons cultured alone.
Expression of NR1, PSD-95, and synaptophysin was reduced
by 76.8%, 80.4%, and 75.3%, respectively, compared with
neurons grown in co-cultures with astrocytes in the absence of
Ab1-40 (P< 0.001) (Figure 7, D and F). This profound loss of
synaptic protein expression was associated with massive intra-
neuronal Ab1-40 accumulation (Figure 7D). The loss of
synaptic protein markers was not associated with degeneration
of the cytoskeleton as shown with the use of a-tubulin, as
a control cytoskeletal protein. TheWestern immunoblot signals
for a-tubulin in lysates of primary hippocampal neurons treated
with Ab1-40 in the absence or presence of astrocytes were
comparable with those of control neurons (Supplemental
Figure S6). Ab12-28P treatment of neurons co-cultured with
astrocytes inhibited the loss of synaptic proteins. Compared
with the primary hippocampal neurons co-cultured with astro-
cytes in the absence of Ab1-40, expression of the NR1 subunit
of NMDAR, PSD-95, and synaptophysin was reduced only by
29%, 26.1%, and 36.5%, respectively (P< 0.001) (Figure 7, E
and F). The therapeutic effect of Ab12-28P on synaptic proteinajp.amjpathol.org - The American Journal of Pathology
Figure 6 Subcellular distribution of internalized Ab1-40 in primary hippocampal neurons. A: Representative microphotographs of control primary
hippocampal neurons cultured alone and immunostained against speciﬁc intracellular organelle markers: early endosome antigen 1 (EEA1) for early endo-
somes, Rab7 for late endosomes, Cathepsin D for late endosomes and lysosomes, and heat shock protein 60 (HSP60) for mitochondria. B: Representative
microphotographs of primary hippocampal neurons cultured alone in the presence of Ab1-40 (traced with 10% of FITC-Ab1-40). Arrows indicate weak
colocalization of internalized Ab1-40 with EEA1, Rab7, Cathepsin D, and HSP60. C: Representative microphotographs of primary hippocampal neurons co-
cultured with astrocytes in the presence of Ab1-40/FITC-Ab1-40. Arrowheads indicate ample amount of intraneuronal Ab1-40 showing colocalization with
Rab7 and Cathepsin D and, to less extent, with HSP60 and EEA1. D: Representative microphotographs of primary hippocampal neurons co-cultured with
astrocytes that were treated with Ab12-28P during the exposure to Ab1-40/FITC-Ab1-40. There is markedly reduced intraneuronal Ab1-40 content, especially
in the late endosomes and lysosomes. Red color represents immunostaining against speciﬁc intracellular organelle markers, whereas green is FITC-Ab1-40.
Scale bars: 5 mM (AeD).
Ab12-28P Reduces Intraneuronal Ab
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Kuszczyk et alexpression was associated with substantial reduction in the
intraneuronal Ab1-40 accumulation (Figure 7E).
Knockout of the Apoe Gene in APPSW/PS1dE9AD Tg Mice
Results in the Absence of Extracellular Fibrillar Ab
Deposits, Whereas TR with ApoE4 Isoform Doubles the
Load of Fibrillar Ab Deposits Compared with TR with
ApoE2 and ApoE3 Isoforms
To investigate the role of ApoE in the in vivo intraneuronal
Ab accumulation, we have generated four novel AD Tg
mice lines, including APPSW/PS1dE9/ApoE2, APPSW/
PS1dE9/ApoE3, APPSW/PS1dE9/ApoE4, and APPSW/PS1dE9/
ApoE KO. These Tg mice were derived from ApoE-TR
mice, where human ApoE isoforms are expressed at the
physiological levels of murine ApoE expression.18,19 For
the ﬁrst time, we have quantiﬁed deposition of extracellular
Ab in these previously uncharacterized AD Tg mice lines,
calculating the average load of ﬁbrillar Ab deposits in the
neocortex in 11-month-old female mice with the use of an
unbiased stereologic principle. The mean ﬁbrillar Ab load in
APPSW/PS1dE9/ApoE2 mice and APPSWPS1dE9/ApoE3
was 0.86%  0.19% and 1.05%  0.18%, respectively
(Figure 8, A and B) (difference not statistically signiﬁcant).
In APPSW/PS1dE9/ApoE4, the ﬁbrillar Ab load was 1.92%
 0.34%, almost twice as high as in mice expressing E2 and
E3 isoforms (P < 0.05). APPSWPS1dE9/ApoE KO mice had
little true amyloid deposits shown by amyloid-binding dyes
X-34 or thioﬂavin-S. Scant deposits were too rare and too
small to be reliably thresholded and quantiﬁed (Figure 8A).
A fair number of nonﬁbrillar Ab deposits could be shown in
APPSWPS1dE9/ApoE KO mice with the use of anti-Ab
immunohistochemistry (Figure 8C). In the various lines of
APPSWPS1dE9/ApoE-TR mice differences in the load of Ab
deposits shown by immunohistochemistry corresponded to
that noted by amyloid-binding dyes.
Knockout of the Apoe Gene in APPSW/PS1dE9AD Tg Mice
Markedly Reduces Intraneuronal Ab Presence
Compared with TR with Human ApoE Isoforms
The effect of ApoE KO and expression of various human
ApoE isoforms on intraneuronal Ab presence was investigated
by confocal microscopy in the pyramidal neurons in the CA1
and CA2/CA3 sectors of the cornu ammonis with the use of
double immunostaining against Ab1-X andMAP2 for neuronal
identiﬁcation. Ab1-X was immunostained with 6E10/4G8
mAbs that gave a bright punctate immunostaining pattern
inside perikarya (Figure 9A). In APPSW/PS1dE9/ApoE KO
mice few neurons showed intraneuronal Ab1-X presence. They
constituted 1.2%  0.3% and 4.3%  0.6%, respectively, of
the total population of pyramidal neurons in the CA1 and
CA2/3 sectors (P < 0.001 against all APPSW/PS1dE9/ApoE-
TR lines) (Figure 9B). In APPSW/PS1dE9/ApoE-TR mice, the
percentage of CA1 neurons with intraneuronal Ab1-X presence
ranged from 39.7% 2.3% in APPSW/PS1dE9/ApoE2 mice to176245.4% 1.6% in the APPSW/PS1dE9/ApoE4 line. In the CA2/
3 sector, the percentage of Ab1-X-positive neurons ranged
from 55.9%  2.0% in the APPSW/PS1dE9/ApoE3 line to
63.1% 2.3% in the APPSW/PS1dE9/ApoE4 line. The fraction
of pyramidal neurons that showed intraneuronal Ab1-X pres-
ence was signiﬁcantly higher in the CA2/3 sector than in the
CA1 sector for all ApoE isoforms (P < 0.001) but not in
APPSW/PS1dE9/ApoE KO mice. Statistically signiﬁcant
differences between particular ApoE isoforms were seen only
in the CA2/3 sector between APPSWPS1dE9/ApoE2 and
APPSWPS1dE9/ApoE4 mice (P < 0.01). To show speciﬁc
immunodetection of intraneuronal Ab presence with a mixture
of 6E10 and 4G8mAbs, with no conﬂicting signals fromAPP,
additional sections were immunostained with mAb HJ7.4
against the carboxy terminus of AbX-42 and Abs against car-
boxy and amino termini of APP (Figure 9C). AbX-42 carboxy-
terminal immunostaining produced a ﬁne, granular pattern that
was associated with a large fraction of pyramidal neurons in
APPSW/PS1dE9/ApoE-TR mice but with few neurons in
APPSW/PS1dE9/ApoE KO mice, akin to that observed with
6E10/4G8 mAb staining. Both anti-APP Abs produced robust
staining of virtually all CA1 and CA2/3 pyramidal neurons in
APPSW/PS1dE9/ApoE KO mice, which was comparable with
that seen in APPSW/PS1dE9/ApoE-TR mice.Discussion
Intraneuronal accumulation of Ab is a potentially important
aspect of AD pathogenesis. Intraneuronal Ab is derived
from Ab internalized by neurons from the extracellular
space through ApoE-dependent and ApoE-independent
uptakes and from intrinsic Ab that escapes exocytosis after
APP cleavage that takes place in the endocytic compart-
ment.34 Disequilibrium between the rate of intraneuronal Ab
accumulation and intraneuronal Ab degradation in AD
neurons results in its intraneuronal buildup. This equilibrium
is further affected by Ab clearance into cerebrospinal ﬂuid
and across the BBB.35 Through its high afﬁnity for Ab and
receptor-mediated clearance, ApoE contributes importantly
to Ab metabolism and intraneuronal uptake. To better char-
acterize effects of astrocyte-derived ApoE on the intra-
neuronal Ab accumulation and to test a hypothesis that an
ApoE/Ab antagonist would effectively lower intraneuronal
Ab level, we set up a noncontact, neuronal-astrocytic co-
culture model. With the use of this model system, we found
signiﬁcantly increased intraneuronal accumulation of Ab
peptides in primary hippocampal neurons co-cultured with
astrocytes compared with neurons cultured alone during
exposure to synthetic Ab peptides in the conditioned media.
To ascertain that the observed effect depends speciﬁcally on
ApoE, we compared intraneuronal Ab1-42 levels between
primary hippocampal neurons co-cultured with ApoE KO
astrocytes and primary hippocampal neurons cultured alone
and found no signiﬁcant differences. We found that the
intraneuronal level of Ab1-40 and Ab1-42 in primaryajp.amjpathol.org - The American Journal of Pathology
Figure 7 Expression of synaptic protein markers in primary hippocampal neurons. A and B: Representative microphotographs of primary hippocampal
neurons immunostained against NR1 subunit of the N-methyl-D-aspartic acid receptor (NMDAR), postsynaptic density protein 95 (PSD-95), and synaptophysin,
which were cultured alone in the absence and presence of Ab1-40 traced with 10% of FITC-Ab1-40, respectively. Arrows in B indicate ﬁne Ab1-40 aggregates
covering the external surface of the dendrites. C and D: Representative microphotographs of primary hippocampal neurons co-cultured with astrocytes in the
absence and presence of Ab1-40/FITC-Ab1-40 in the conditioned media, respectively. Arrowheads in D indicate intraneuronal Ab1-40 accumulation in the
perykaryon and proximal segments of primary dendrites. E: Representative microphotographs of primary hippocampal neurons co-cultured with astrocytes in
the presence of Ab1-40/FITC-Ab1-40 in the conditioned media, which were also cotreated with Ab12-28P. Red color represents immunostaining against
speciﬁc synaptic proteins, green is FITC-Ab1-40, whereas blue is DAPI nuclear counterstaining. Rectangular areas covering section of dendrites of neurons
immunostained against PSD-95 are enlarged directly underneath each image and represent example test ﬁelds selected for quantiﬁcation of synaptic protein
expression. For antibodies that control staining, see Supplemental Figure S3. F: Quantitative analysis of synaptic protein expression. Values show means  SD
density of synaptic proteins along primary and secondary dendrites relative to those in primary hippocampal neurons cultured alone without Ab40 in three
independent experiments. One-way analysis of variance P < 0.0001 for all three synaptic proteins. Post hoc Tukey’ s HSD test values are displayed on the graph
for pairs of columns with statistically signiﬁcant differences. ***P < 0.001. Scale bars: 20 mM (A); 2 mM (enlarged area in A).
Ab12-28P Reduces Intraneuronal Abhippocampal neurons co-cultured with astrocytes can be
effectively lowered with Ab12-28P, which is a well-
established inhibitor of ApoE/Ab binding,16,22 but not with
a peptide representing its scrambled sequence. Furthermore,
Ab12-28P treatment had no effect on the intraneuronal Ab
level in primary hippocampal neurons cultured alone, which
again indicates that ApoE is required for its pharmacody-
namic effect. The level of ApoE in the conditionedmedia was
also veriﬁed and showed no signiﬁcant variability among
different treatment conditions, which could account forThe American Journal of Pathology - ajp.amjpathol.orgdifferences in the uptake of Ab peptides from the media and
their intraneuronal accumulation. As shown by us and others,
ApoE facilitates but it is not required for Ab uptake, because
neurons grown in the absence of ApoE can internalize Ab.28
However, ApoE can greatly increase the tempo of Ab
internalization by binding Ab in the extracellular space and
directing it to neurons, which internalize ApoE/Ab
complexes through highly efﬁcient receptor-mediated endo-
cytosis. Besides ﬁnding a strong effect of ApoE on increasing
the intraneuronal level of both Ab1-40 and Ab1-42, we also1763
Figure 8 Analysis of extracellular Ab deposits in APPSW/PSdE9/ApoE KO
and APPSW/PSdE9/ApoE-TR lines. A: Representative microphotographs of
thioﬂavin-Sestained coronal brain sections from APPSW/PSdE9/ApoE KO and
APPSW/PSdE9/ApoE-TR mice involving the hippocampus, the cingulate
cortex, and the somatosensory cortex. B: Unbiased quantiﬁcation of the
ﬁbrillar Ab load in the neocortex of 11-month-old female APPSW/PSdE9/
ApoE-TR mice, which are homozygotes for E2, E3, and E4 alleles. Values are
given as means  SEM (nZ 8 per group). Statistical signiﬁcance between
particular transgenic lines was analyzed with U-test, whose values, if
signiﬁcant, are depicted in the ﬁgure. *P < 0.05. C: Representative
microphotographs of coronal brain sections involving the hippocampus, the
cingulated cortex, and the somatosensory cortex, which were immuno-
stained against Ab1-X. Scale bars: 500 mM (A and C).
Kuszczyk et alshowed that ApoE promotes intraneuronal oligomerization
of both Ab1-40 and Ab1-42 peptides and impairs intra-
neuronal Ab1-40 clearance. Unlike the well-recognized
effect of ApoE on promoting Ab ﬁbrillization,36 its effect
on Ab oligomerization has been underappreciated until
recently. Several recent studies provided evidence to support
increased content of Ab oligomers in the extracellular space
in brains of patients with AD, expressing the human ApoE41764isoform,37,38 and intraneuronally in mice expressing human
ApoE4 isoform after inhibition of Ab-degrading enzyme
neprilysin.39
Because various ApoE receptors play an important role in
Ab metabolism, the effect of their overexpression on Ab
pathology has been studied with various model systems.
Overexpression of low-density lipoprotein receptor-related
protein (LRP) in several neuronal cell lines resulted in
increased intraneuronal Ab accumulation.15,40 LRP over-
expression in APPV717F mice, besides augmenting intra-
neuronal Ab accumulation, exacerbated the memory deﬁcit
and caused an increase in soluble Ab level in the brain.41
A contrasting effect was seen in APPSW/PS1dE9/LDLR
mice that overexpress low-density lipoprotein receptor
(LDLR), which together with LRP constitute two main
ApoE receptors in the brain. APPSW/PS1dE9/LDLR mice
showed increased clearance of Ab from the extracellular
space and inhibition of Ab deposition.21 These mice over-
express LDLR in neurons and astrocytes, which indicates
that the protective effect of LDLR up-regulation can be
related to the receptor subtype and/or its overexpression in
nonneuronal cells capable of efﬁcient Ab degradation.42 In
addition, treatment of several AD Tg mice models with liver
X receptor or retinoid X receptor agonists, which up-
regulate ApoE expression and enhance its lipidation
status, resulted in reduction of Ab plaque load through
enhancing clearance of Ab by glial cells.43,44 These pub-
lished data indicate that the ApoE/Ab interaction may result
in multidirectional effects that may promote Ab degradation
by nonneuronal cells43,44 while enhancing Ab accumulation
in neurons. In our studies, we analyzed levels of Ab
peptides in the conditioned media at the conclusion of the
experiment, and we found that their levels in the co-culture
systems are markedly lower than those in neuronal mono-
cultures. This difference may be explained by the presence
of astrocytes in the co-culture system, which shows robust
capacity for clearance of Ab from extracellular space and its
intracellular degradation. Thus, neurons co-cultured with
astrocytes appear to accumulate more Ab internally despite
reduction in Ab level in the condition media, which implies
that astrocytes play a double-edged sword role by clearing
Ab from the media and at the same time producing ApoE
that promotes intraneuronal Ab accumulation. Ab12-28P
treatment of neurons co-cultured with astrocytes reduced the
intraneuronal levels of Ab peptides below that detected in
neurons cultured alone, because it blocked ApoE-mediated
Ab internalization, whereas ApoE-independent Ab uptake
was limited because of reduced Ab concentration in the
conditioned media.
Confocal microscopy imaging of neurons from astrocytic
co-cultures showed increased Ab content in the endosomal/
lysosomal compartment, which is consistent with internali-
zation of ApoE/Ab complexes through receptor-mediated
endocytosis, directing the complex to the endosomal/
lysosomal system. Consistent with our current obser-
vations, overexpression of LRP facilitated endocytosis ofajp.amjpathol.org - The American Journal of Pathology
Figure 9 Analysis of intraneuronal Ab accumula-
tion in APPSW/PSdE9/ApoE KO and APPSW/PSdE9/ApoE-
TR lines.A: Representative confocalmicroscopy images
1 mm thick through the body of pyramidal neurons in
the CA1 sector of the cornu ammonis immunostained
with a mixture of 6E10/4G8 monoclonal antibodies
against intraneuronal Ab1-X (green channel). Neurons
were identiﬁed by MAP2 immunostaining (red chan-
nel).Arrowheads indicate intraneuronal aggregates of
Ab1-X. B: Quantitative analysis of Ab1-X-positive
neurons in the CA1 and CA2/CA3 sectors of the cornu
ammonis in APPSW/PSdE9/ApoE KO and APPSW/PSdE9/
ApoE-TR lines. Analysis of varianceP< 0.0001 for both
sectors and ApoE isoform effect. Values of the post hoc
analysis that used Bonferroni’s test are displayed on
the graph for pairs of columns with statistically
signiﬁcant differences. **P< 0.01, ***P< 0.001. C:
Comparison of immunostainings with monoclonal
antibody HJ7.4 against carboxy terminus of AbX-42 and
antibodies against amino or carboxy termini of APP
(red) with DAPI counterstaining (blue) in CA1 pyra-
midal layer neurons in APPSW/PSdE9/ApoE3 and APPSW/
PSdE9/ApoE KO lines. For antibody control staining, see
Supplemental Figure S3. APP, amyloid precursor
protein; CT, carboxy terminus; NT, amino ter-
minus; MAP2, microtubule-associated protein 2.
Scale bars: 25 mm (A and C AbX-42); 25 mm (C APP
NT and APP CT).
Ab12-28P Reduces Intraneuronal AbApoE-containing lipid particles in APPV717F mice, resulting
in marked increase in the intraneuronal Ab content, which
colocalized with the lysosomal-associated membrane
protein 1 lysosomal marker.15 In contrast, evidence suggests
that internalization of Ab not associated with ApoE occurs
through nonendocytotic mechanisms, which are based on
the translocation of the cell surface bound Ab directly to the
cytosol and results in accumulation of Ab primarily outside
the endosomal/lysosomal compartment.28,45,46
Synapses, and in particular excitatory synapses of hippo-
campal neurons, are early targets of Ab toxicity. Synaptotox-
icity appears to concern both extracellular and intracellular Ab.
We showed that the loss of the NMDARNR1 subunit, PSD-95,
and synaptophysin expression in neuronal monocultures where
confocal microscopy detected mainly extraneuronal Ab1-40
aggregates, whereas more pronounced loss of these synaptic
proteins was seen in neurons co-cultured with astrocytes, which
also showed marked buildup of intraneuronal oligomers. It has
been previously reported that extracellular application of Ab
oligomers to primary neuronal cultures or organotypic hippo-
campal slices induce rapid changes in the structure and density
of synaptic spines47,48 and reduces expression of NMDARs and
related synaptic proteins,49 through several signaling pathways,
one of which involves the a-7 nicotinic receptor.49 Loss of the
NMDAR NR1 subunit and PSD-95 was also found in cultures
of primary hippocampal neurons derived from APPSW mice.
These cultures are characterized by progressive buildup of
intraneuronal Ab, which is derived from endogenous Ab
escaping exocytosis after cleavage of the APPSW mutant.
9,49 In
this model, Ab accumulates along the endosomal/lysomal
pathway that leads to dysfunction of multivesicular bodies,The American Journal of Pathology - ajp.amjpathol.orgcausing impairment of the ubiquitin-proteasome system,9which
also controls the fate of NMDARs undergoing endocytic
vesicular trafﬁcking.50 ApoE-promoted buildup of Ab oligo-
mers along the endosomal/lysosomal pathway may therefore
affect intracellular trafﬁcking and sorting of synaptic proteins
and may indicate a way in which intracellular Ab contributes to
synaptic degeneration. Furthermore, several AD Tg animal
models are characterized by early and massive intraneuronal
accumulation of Ab oligomers, loss of synaptic proteins, and
behavioral impairment which occur in the absence of extra-
cellular Ab plaques.7,51 In particular, in 3Tg-AD mice
(APPSW/PS1M146V/TauP301L), intraneuronal Ab accumulation
may predate formation of Ab plaques and neuroﬁbrillary
pathology and shows temporal correlation with synaptic
dysfunction, emphasizing the role of intraneuronal Ab in
neurodegeneration.52,53
The APOE alleles are a well-recognized genetic risk factor
for sporadic AD and correlate with severity of b-amyloid-
osis.13 Inheritance of APOE4 increases AD risk, whereas
APOE2 shows a relative protective effect. APPSW/PS1dE9/
ApoE KO and APPSW/PS1dE9/ApoE-TR mice are new Tg
lines produced to investigate the role of ApoE in Ab
pathology. The APPSW/PS1dE9 line represents a Tg model
with enhanced disease phenotype, whereby the ﬁrst plaques
are detected by thioﬂavin-S at the age of 4 months.54 Despite
such aggressive development of Ab pathology, the ApoE KO
resulted in virtual absence of ﬁbrillar Ab deposits, which
emphasizes a critical effect of ApoE on Ab ﬁbrillization and
deposition. Similar effects of the ApoE KO were previously
reported in APPV717F and APPSW lines, representing more
latent models of Ab pathology in which thioﬂavin-S detects1765
Kuszczyk et althe ﬁrst plaques around the age of 1 year.14,55 TR ofAPOE4 in
APPSW/PS1dE9 mice was associated with a twofold increase
in the load of extracellular Ab deposits compared with TR of
APOE2 or APOE3, with all lines of mice showing substantial
Ab load at 11months of age. Thus far, the differential effect of
targeted ApoE isoform replacement on Ab pathology has
been reproduced in single APPV717F mice, which had to be at
least 18 months of age to observe substantial Ab load.56,57
Thus, APPSW/PS1dE9/ApoE-TR mice represent an impor-
tant advance in modeling the effect of human ApoE isoforms
onAb pathology, allowing us to conduct studies, for example,
on novel AD therapeutics, in animals of much younger age.
ApoE KO in APPSW/PS1dE9 mice was associated with
a marked reduction in intraneuronal Ab presence. Because
lack of ApoE should not have any effect on the noneApoE-
mediated pathways of Ab uptake and accrual of endogenous
Ab remnants from APP cleavage, this experiment provides
evidence to support the pivotal role of ApoE in intra-
neuronal Ab accumulation, complementing our ex vivo data.
For immunocytochemical detection of intraneuronal Ab
presence, we used a mixture of mAbs 6E10/4G8, which,
although under certain conditions can cross-detect APP, in
our staining gave primarily intraneuronal punctate pattern.
This punctate pattern was different from the diffuse pattern
of membrane staining seen when anti-APP antibodies were
used in the control experiment. Furthermore, we have
conﬁrmed reduction in the intraneuronal Ab presence
associated with ApoE KO with the use of AbX-42 C-
terminal-speciﬁc mAb HJ7.4. Similar to observations in
APPSW/PS1dE9/ApoE KO mice, KO of ApoE in APPV717F
mice was also reported to cause marked reduction in the
intraneuronal Ab accumulation.15 Despite differences in the
extraneuronal Ab load, no signiﬁcant effect of human ApoE
isoforms on the number of Ab-bearing neurons in APPSW/
PS1dE9/ApoE-TR mice was observed, although it cannot be
excluded that the actual intraneuronal Ab level can vary
between ApoE isoforms. As shown in another model
involving inhibition of the Ab-degrading enzyme neprilysin,
intraneuronal oligomerization and accumulation of Ab
occurred more readily in mice that expressed the ApoE4
isoform than the ApoE3 isoform.39
We demonstrated that blocking the ApoE/Ab interaction
with the use of Ab12-28P reduces intraneuronal Ab1-40 and
Ab1-42 accumulation, including levels of intraneuronal
Ab1-40 and Ab1-42 oligomers, and inhibits loss of synaptic
proteins. Few other therapies have shown effects against
intraneuronal Ab. Limited examples include application of
anti-Ab mAbs into neuronal culture derived from APPSW
mice, whereby mAbs after binding to extracellular APP
domain became internalized, resulting in reduced intra-
neuronal Ab accumulation.58 Although these in vitro
observations indicate that anti-Ab mAbs can be helpful in
targeting intraneuronal Ab, for in vivo application, limited
BBB permeability of anti-Ab mAbs may thwart their ther-
apeutic potency in respect to lowering intraneuronal Ab
level, despite being effective in reducing Ab plaque load,1766which primarily occurs through the peripheral sink mecha-
nism.59 In fact, transient clearance of intraneuronal Ab in
3Tg-AD mice was reported by intraventricularly but not
systemically delivered immunotherapy.53 Ab12-28P is
a nontoxic synthetic peptide that was modiﬁed for in vivo
application, and its BBB permeability was previously
evaluated and reported.16 We have used Ab12-28P in the
past to successfully reduce Ab plaques load and CAA in
APPSW and APPSW/PS1M146L AD model mice.
22 Our
previous and current experiments indicate that the antago-
nist of the ApoE/Ab interaction can be effective in both
reducing extracellular and intracellular Ab deposition.
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